Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt 1.32
SPAN's Cash to Debt is ranked lower than
60% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. SPAN: 1.32 )
Ranked among companies with meaningful Cash to Debt only.
SPAN' s Cash to Debt Range Over the Past 10 Years
Min: 0.22  Med: 10000.00 Max: No Debt
Current: 1.32
Equity to Asset 0.76
SPAN's Equity to Asset is ranked higher than
69% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. SPAN: 0.76 )
Ranked among companies with meaningful Equity to Asset only.
SPAN' s Equity to Asset Range Over the Past 10 Years
Min: 0.58  Med: 0.78 Max: 0.86
Current: 0.76
0.58
0.86
Interest Coverage 683.63
SPAN's Interest Coverage is ranked higher than
51% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 481.81 vs. SPAN: 683.63 )
Ranked among companies with meaningful Interest Coverage only.
SPAN' s Interest Coverage Range Over the Past 10 Years
Min: 69.61  Med: 681.22 Max: 9999.99
Current: 683.63
69.61
9999.99
F-Score: 7
Z-Score: 8.20
M-Score: -2.52
WACC vs ROIC
3.18%
17.02%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 7.81
SPAN's Operating margin (%) is ranked higher than
66% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.89 vs. SPAN: 7.81 )
Ranked among companies with meaningful Operating margin (%) only.
SPAN' s Operating margin (%) Range Over the Past 10 Years
Min: 6.46  Med: 10.16 Max: 13.42
Current: 7.81
6.46
13.42
Net-margin (%) 5.95
SPAN's Net-margin (%) is ranked higher than
65% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. SPAN: 5.95 )
Ranked among companies with meaningful Net-margin (%) only.
SPAN' s Net-margin (%) Range Over the Past 10 Years
Min: 4.64  Med: 6.86 Max: 8.61
Current: 5.95
4.64
8.61
ROE (%) 15.69
SPAN's ROE (%) is ranked higher than
83% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. SPAN: 15.69 )
Ranked among companies with meaningful ROE (%) only.
SPAN' s ROE (%) Range Over the Past 10 Years
Min: 8.52  Med: 16.53 Max: 31.29
Current: 15.69
8.52
31.29
ROA (%) 12.34
SPAN's ROA (%) is ranked higher than
89% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: -0.07 vs. SPAN: 12.34 )
Ranked among companies with meaningful ROA (%) only.
SPAN' s ROA (%) Range Over the Past 10 Years
Min: 7.17  Med: 13.25 Max: 20.31
Current: 12.34
7.17
20.31
ROC (Joel Greenblatt) (%) 42.20
SPAN's ROC (Joel Greenblatt) (%) is ranked higher than
87% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. SPAN: 42.20 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SPAN' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 24.67  Med: 46.41 Max: 58.91
Current: 42.2
24.67
58.91
Revenue Growth (3Y)(%) -6.10
SPAN's Revenue Growth (3Y)(%) is ranked lower than
75% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. SPAN: -6.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
SPAN' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -6.1  Med: 5.90 Max: 16.8
Current: -6.1
-6.1
16.8
EBITDA Growth (3Y)(%) -8.10
SPAN's EBITDA Growth (3Y)(%) is ranked lower than
65% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. SPAN: -8.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SPAN' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -15  Med: 2.30 Max: 46.6
Current: -8.1
-15
46.6
EPS Growth (3Y)(%) -9.10
SPAN's EPS Growth (3Y)(%) is ranked lower than
65% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. SPAN: -9.10 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SPAN' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -17.8  Med: 2.20 Max: 133.6
Current: -9.1
-17.8
133.6
» SPAN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

SPAN Guru Trades in Q1 2015

Jim Simons 61,000 sh (+4.10%)
» More
Q2 2015

SPAN Guru Trades in Q2 2015

Jim Simons 63,200 sh (+3.61%)
» More
Q3 2015

SPAN Guru Trades in Q3 2015

Jim Simons 64,100 sh (+1.42%)
» More
Q4 2015

SPAN Guru Trades in Q4 2015

Jim Simons 66,400 sh (+3.59%)
» More
» Details

Insider Trades

Latest Guru Trades with SPAN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 14.55
SPAN's P/E(ttm) is ranked higher than
78% of the 260 Companies
in the Global Medical Devices industry.

( Industry Median: 28.39 vs. SPAN: 14.55 )
Ranked among companies with meaningful P/E(ttm) only.
SPAN' s P/E(ttm) Range Over the Past 10 Years
Min: 4.97  Med: 11.28 Max: 22.57
Current: 14.55
4.97
22.57
Forward P/E 11.31
SPAN's Forward P/E is ranked higher than
84% of the 182 Companies
in the Global Medical Devices industry.

( Industry Median: 18.42 vs. SPAN: 11.31 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 14.55
SPAN's PE(NRI) is ranked higher than
80% of the 200 Companies
in the Global Medical Devices industry.

( Industry Median: 27.40 vs. SPAN: 14.55 )
Ranked among companies with meaningful PE(NRI) only.
SPAN' s PE(NRI) Range Over the Past 10 Years
Min: 4.94  Med: 10.60 Max: 22.57
Current: 14.55
4.94
22.57
P/B 2.18
SPAN's P/B is ranked higher than
56% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. SPAN: 2.18 )
Ranked among companies with meaningful P/B only.
SPAN' s P/B Range Over the Past 10 Years
Min: 1.12  Med: 1.85 Max: 5.6
Current: 2.18
1.12
5.6
P/S 0.90
SPAN's P/S is ranked higher than
80% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 2.18 vs. SPAN: 0.90 )
Ranked among companies with meaningful P/S only.
SPAN' s P/S Range Over the Past 10 Years
Min: 0.4  Med: 0.76 Max: 1.42
Current: 0.9
0.4
1.42
PFCF 16.26
SPAN's PFCF is ranked higher than
87% of the 205 Companies
in the Global Medical Devices industry.

( Industry Median: 34.47 vs. SPAN: 16.26 )
Ranked among companies with meaningful PFCF only.
SPAN' s PFCF Range Over the Past 10 Years
Min: 5.26  Med: 11.27 Max: 218.83
Current: 16.26
5.26
218.83
POCF 13.63
SPAN's POCF is ranked higher than
79% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 19.47 vs. SPAN: 13.63 )
Ranked among companies with meaningful POCF only.
SPAN' s POCF Range Over the Past 10 Years
Min: 4.56  Med: 9.85 Max: 25.29
Current: 13.63
4.56
25.29
EV-to-EBIT 9.09
SPAN's EV-to-EBIT is ranked higher than
87% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 24.10 vs. SPAN: 9.09 )
Ranked among companies with meaningful EV-to-EBIT only.
SPAN' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.1  Med: 7.00 Max: 14.8
Current: 9.09
3.1
14.8
EV-to-EBITDA 7.48
SPAN's EV-to-EBITDA is ranked higher than
86% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 16.11 vs. SPAN: 7.48 )
Ranked among companies with meaningful EV-to-EBITDA only.
SPAN' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.8  Med: 5.90 Max: 11.1
Current: 7.48
2.8
11.1
Shiller P/E 12.73
SPAN's Shiller P/E is ranked higher than
94% of the 72 Companies
in the Global Medical Devices industry.

( Industry Median: 31.42 vs. SPAN: 12.73 )
Ranked among companies with meaningful Shiller P/E only.
SPAN' s Shiller P/E Range Over the Past 10 Years
Min: 9.03  Med: 13.38 Max: 38.18
Current: 12.73
9.03
38.18
Current Ratio 2.59
SPAN's Current Ratio is ranked lower than
52% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.66 vs. SPAN: 2.59 )
Ranked among companies with meaningful Current Ratio only.
SPAN' s Current Ratio Range Over the Past 10 Years
Min: 2.35  Med: 3.48 Max: 4.67
Current: 2.59
2.35
4.67
Quick Ratio 1.37
SPAN's Quick Ratio is ranked lower than
66% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. SPAN: 1.37 )
Ranked among companies with meaningful Quick Ratio only.
SPAN' s Quick Ratio Range Over the Past 10 Years
Min: 1.37  Med: 2.57 Max: 3.78
Current: 1.37
1.37
3.78
Days Inventory 51.80
SPAN's Days Inventory is ranked higher than
86% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 142.23 vs. SPAN: 51.80 )
Ranked among companies with meaningful Days Inventory only.
SPAN' s Days Inventory Range Over the Past 10 Years
Min: 37.51  Med: 51.09 Max: 69.02
Current: 51.8
37.51
69.02
Days Sales Outstanding 48.38
SPAN's Days Sales Outstanding is ranked higher than
77% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 72.25 vs. SPAN: 48.38 )
Ranked among companies with meaningful Days Sales Outstanding only.
SPAN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.24  Med: 43.34 Max: 49.7
Current: 48.38
38.24
49.7
Days Payable 19.71
SPAN's Days Payable is ranked lower than
91% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 59.85 vs. SPAN: 19.71 )
Ranked among companies with meaningful Days Payable only.
SPAN' s Days Payable Range Over the Past 10 Years
Min: 17.2  Med: 24.07 Max: 34.51
Current: 19.71
17.2
34.51

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 3.20
SPAN's Dividend Yield is ranked higher than
87% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.72 vs. SPAN: 3.20 )
Ranked among companies with meaningful Dividend Yield only.
SPAN' s Dividend Yield Range Over the Past 10 Years
Min: 0.89  Med: 2.65 Max: 4.38
Current: 3.2
0.89
4.38
Dividend Payout 0.46
SPAN's Dividend Payout is ranked lower than
64% of the 122 Companies
in the Global Medical Devices industry.

( Industry Median: 0.34 vs. SPAN: 0.46 )
Ranked among companies with meaningful Dividend Payout only.
SPAN' s Dividend Payout Range Over the Past 10 Years
Min: 0.17  Med: 0.26 Max: 0.66
Current: 0.46
0.17
0.66
Dividend Growth (3y) 9.10
SPAN's Dividend Growth (3y) is ranked higher than
66% of the 64 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. SPAN: 9.10 )
Ranked among companies with meaningful Dividend Growth (3y) only.
SPAN' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 5  Med: 9.10 Max: 27.4
Current: 9.1
5
27.4
Forward Dividend Yield 3.31
SPAN's Forward Dividend Yield is ranked higher than
88% of the 176 Companies
in the Global Medical Devices industry.

( Industry Median: 1.76 vs. SPAN: 3.31 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 4.99
SPAN's Yield on cost (5-Year) is ranked higher than
86% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.87 vs. SPAN: 4.99 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
SPAN' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.39  Med: 4.13 Max: 6.83
Current: 4.99
1.39
6.83
3-Year Average Share Buyback Ratio -0.70
SPAN's 3-Year Average Share Buyback Ratio is ranked higher than
68% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: -4.30 vs. SPAN: -0.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SPAN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -2.6  Med: -1.40 Max: 7.9
Current: -0.7
-2.6
7.9

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 4.78
SPAN's Price/Net Current Asset Value is ranked higher than
61% of the 299 Companies
in the Global Medical Devices industry.

( Industry Median: 8.50 vs. SPAN: 4.78 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
SPAN' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 1.3  Med: 2.90 Max: 17.9
Current: 4.78
1.3
17.9
Price/Tangible Book 2.89
SPAN's Price/Tangible Book is ranked higher than
66% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 4.04 vs. SPAN: 2.89 )
Ranked among companies with meaningful Price/Tangible Book only.
SPAN' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.73  Med: 1.59 Max: 4.4
Current: 2.89
0.73
4.4
Price/Projected FCF 0.94
SPAN's Price/Projected FCF is ranked higher than
84% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: 1.87 vs. SPAN: 0.94 )
Ranked among companies with meaningful Price/Projected FCF only.
SPAN' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.35  Med: 0.81 Max: 1.73
Current: 0.94
0.35
1.73
Price/Median PS Value 1.19
SPAN's Price/Median PS Value is ranked lower than
69% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. SPAN: 1.19 )
Ranked among companies with meaningful Price/Median PS Value only.
SPAN' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.48  Med: 0.84 Max: 1.37
Current: 1.19
0.48
1.37
Price/Graham Number 1.32
SPAN's Price/Graham Number is ranked higher than
69% of the 269 Companies
in the Global Medical Devices industry.

( Industry Median: 2.92 vs. SPAN: 1.32 )
Ranked among companies with meaningful Price/Graham Number only.
SPAN' s Price/Graham Number Range Over the Past 10 Years
Min: 0.58  Med: 0.94 Max: 1.59
Current: 1.32
0.58
1.59
Earnings Yield (Greenblatt) (%) 11.03
SPAN's Earnings Yield (Greenblatt) (%) is ranked higher than
91% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.70 vs. SPAN: 11.03 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SPAN' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 6.8  Med: 14.30 Max: 32.2
Current: 11.03
6.8
32.2
Forward Rate of Return (Yacktman) (%) 1.91
SPAN's Forward Rate of Return (Yacktman) (%) is ranked lower than
61% of the 108 Companies
in the Global Medical Devices industry.

( Industry Median: 5.28 vs. SPAN: 1.91 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
SPAN' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 0.8  Med: 17.20 Max: 44.8
Current: 1.91
0.8
44.8

More Statistics

Revenue(Mil) $70
EPS $ 1.43
Beta0.19
Short Percentage of Float0.43%
52-Week Range $16.44 - 21.62
Shares Outstanding(Mil)2.73

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Span-America Medical Systems Inc was incorporated under the laws of the state of South Carolina on September 21, 1970. The Company manufactures and distributes therapeutic support surfaces, mattress overlays, patient positioners, seating cushions, skin care products and fall prevention products for the medical market and pillows, mattress pads and various foam products for the custom products market throughout the United States and Canada. Its operations are divided into two main business units or segments: medical and custom products. The Company's main medical products consist of polyurethane foam mattress overlays, therapeutic support surfaces (which consist of non-powered and powered therapeutic support surfaces) and patient positioners as well as Selan (r) skin care, seating and fall protection products. The Company's custom products segment includes two product lines namely consumer bedding products and various engineered industrial products. The Company's consumer product line consists mainly of convoluted and contour-cut mattress overlays and specially designed pillows for the consumer bedding market. It sells these products mainly in North America to customers in the segments of the health care market, including acute care hospitals, long-term care facilities and home health care providers. The Company's manufacturing operations are subject to various government regulations pertaining to the discharge of materials into the environment.
» More Articles for SPAN

Headlines

Articles On GuruFocus.com
7 Stocks Paying More Cash with Higher Dividends Aug 12 2013 
Span-America Medical Systems: 92nd Consecutive Dividend and Debt Free Dec 04 2012 
Heinz Increases Dividend 7.3%, And These 5 Other Stocks Raised Dividends May 28 2012 
Guru Stocks Raising Dividends: CATO, POR, VIA, SPAN, HPQ May 28 2012 
11 Cheapest Healthcare Dividend Stocks to Consider Aug 02 2011 
Span-America (SPAN) – 2010 Review + Future Outlook Jan 20 2011 
SpanAmerica Medical Systems Inc. Reports Operating Results (10-Q) Feb 16 2010 
SpanAmerica Medical Systems Inc. Reports Operating Results (10-Q) Feb 10 2009 

More From Other Websites
SPAN AMERICA MEDICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Feb 08 2016
Span-America Medical Systems, Inc. Earnings Analysis: Q1, 2016 By the Numbers Feb 08 2016
SPAN AMERICA MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 04 2016
Span-America Reports Improved First Quarter 2016 Results Feb 04 2016
Q1 2016 Span-America Medical Systems Inc Earnings Release - After Market Close Feb 04 2016
Span-America Medical Systems To Release First Quarter Fiscal 2016 Results On February 4, 2016 Jan 25 2016
SPAN AMERICA MEDICAL SYSTEMS INC Financials Jan 07 2016
SPAN AMERICA MEDICAL SYSTEMS INC Files SEC form 10-K, Annual Report Jan 04 2016
Span-America Medical Systems, Inc. Earnings Analysis: Q4, 2015 By the Numbers Dec 16 2015
Declares Quarterly Cash Dividend Nov 24 2015
Span-America Declares Quarterly Cash Dividend Nov 20 2015
Reports Fourth Quarter and Fiscal Year 2015 Results, Nov 10 2015
SPAN AMERICA MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 09 2015
Span-America Reports Improved Fourth Quarter and Fiscal Year 2015 Results Nov 09 2015
Span-America Medical Systems To Release Fourth Quarter Fiscal 2015 Results On November 9, 2015 Nov 02 2015
Are These Insiders Giving Away Valuable Short-Selling Trading Ideas? Oct 09 2015
Span-America Repurchases 261,310 Shares From Former Director Robert B. Johnston and the Jerry Zucker... Oct 05 2015
SPAN AMERICA MEDICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Oct 02 2015
Span-America Repurchases 261,310 Shares from Former Director Robert B. Johnston and the Jerry Zucker... Oct 02 2015
SPAN AMERICA MEDICAL SYSTEMS INC Files SEC form 10-Q, Quarterly Report Aug 11 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK